Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
The Company reaffirms its 2022 outlook provided in its March 1st, 2022 earnings release, including:
2022 Revenue is expected to approximate $2.7 billion; up high single digits versus FY 2021; 2022
Kontoor Brands (NYSE:KTB) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement.
Analysts estimate that Kontoor Brands will report an earnings per share (EPS) of $0.79.